Kenvue, which makes powerhouse consumer health brands such as Listerine mouthwash and pain reliever Tylenol, saw its second-quarter sales slip 4%, the company also reported on Monday.

Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what some investors expect will be the groundwork for an eventual sale of the ...

The Summit, N.J., drugmaker on Monday named director Kirk Perry interim chief executive officer after Mongon's departure from the company and board. The company also said a strategic review is ...

U.S. companies are removing their CEOs at the fastest clip in two decades, data shows, as increased scrutiny from ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the company is considering simplifying its portfolio amid a recent sales slump.

Kenvue said Monday that its board was taking steps to realize shareholder value and allow the company to “reach its full ...

Mongon’s departure follows the appointment of a new chief financial ... the company delivers its full quarterly earnings in early August. The post Kenvue stock rises on CEO exit as company launches ...

By Pushkala Aripaka and Emma Rumney (Reuters) -Diageo CEO Debra Crew has stepped down after two years in the job, the world's biggest spirits maker said on Wednesday, with finance chief Nik Jhangiani ...

Kenvue CEO steps down amid poor performance and ongoing strategic review. High debt load and rising rates strain Kenvue’s free cash flow and dividend sustainability. Net debt-to-EBITDA at 3.06x ...

Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.

Kenvue says that Thibaut Mongon is leaving as CEO as the maker of Listerine and Band-Aid brands continues with a strategic review of the company. Kenvue used to be a part of Johnson & Johnson.